MagBiosense, Inc. is a private, medical device company focused on the development of a breakthrough high-sensitivity, diagnostic device for use at the point-of-care. MagBiosense is the first to offer both ultra-high sensitivity and the convenience of a point-of-care (POC) device. Our Magnetic Modulation Biosensing (MMB) technology uniquely combines magnetic and fluorescent labeling of target biomarkers, such as cTnI, and applies an external magnetic field to increase fluorescence sensitivity. MMB reduces the diagnosis time of a heart attack by 65%, and thereby offering faster treatment, reduced ED dwell times, and decreased costs.